PMID: 32147984Mar 10, 2020Paper

Brain 18F-FDG-PET: Utility in the Diagnosis of Dementia and Epilepsy

The Israel Medical Association Journal : IMAJ
Eyal LotanTimothy M Shepherd

Abstract

The authors reviewed the two most common current uses of brain 18F-labeled fluoro-2-deoxyglucose positron emission tomography (FDG-PET) at a large academic medical center. For epilepsy patients considering surgical management, FDG-PET can help localize epileptogenic lesions, discriminate between multiple or discordant EEG or MRI findings, and predict prognosis for post-surgical seizure control. In elderly patients with cognitive impairment, FDG-PET often demonstrates lobar-specific patterns of hypometabolism that suggest particular underlying neurodegenerative pathologies, such as Alzheimer's disease. FDG-PET of the brain can be a key diagnostic modality and contribute to improved patient care.

Related Concepts

Related Feeds

Alzheimer's Disease: Neuroimaging

Neuroimaging can help identify pathological hallmarks of Alzheimer's disease (AD). Here is the latest research on neuroimaging modalities, including magnetic resonance imaging and positron emission tomography, in AD.

Related Papers

Nihon rinsho. Japanese journal of clinical medicine
Manabu Tashiro
Fukuoka igaku zasshi = Hukuoka acta medica
Y Ichiya
Journal of Alzheimer's Disease : JAD
David BergeronRobert Laforce
© 2021 Meta ULC. All rights reserved